ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 255 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $407,000 | +92.9% | 41,467 | +135.8% | 0.04% | +375.0% |
| Q2 2018 | $211,000 | -51.5% | 17,588 | -50.1% | 0.01% | -50.0% |
| Q1 2018 | $435,000 | -54.9% | 35,247 | -46.9% | 0.02% | -56.8% |
| Q4 2017 | $965,000 | -53.0% | 66,355 | -54.0% | 0.04% | -51.3% |
| Q3 2017 | $2,053,000 | +63.6% | 144,259 | +46.0% | 0.08% | +52.0% |
| Q2 2016 | $1,255,000 | -18.3% | 98,836 | -15.1% | 0.05% | -18.0% |
| Q1 2016 | $1,537,000 | +255.8% | 116,388 | +314.8% | 0.06% | +258.8% |
| Q4 2015 | $432,000 | -37.1% | 28,060 | -49.4% | 0.02% | -46.9% |
| Q3 2015 | $687,000 | -69.4% | 55,409 | -66.9% | 0.03% | -52.9% |
| Q3 2014 | $2,248,000 | +40.2% | 167,537 | +67.7% | 0.07% | +58.1% |
| Q2 2014 | $1,603,000 | +213.7% | 99,881 | +190.6% | 0.04% | +186.7% |
| Q3 2013 | $511,000 | -79.7% | 34,365 | -82.3% | 0.02% | -82.1% |
| Q2 2013 | $2,519,000 | – | 194,648 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
| EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
| Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
| KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
| Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
| Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |